The sodium phosphate cotransporter family and nicotinamide phosphoribosyltransferase contribute to the daily oscillation of plasma inorganic phosphate concentration-Reference-Cited by-同舟云学术

The sodium phosphate cotransporter family and nicotinamide phosphoribosyltransferase contribute to the daily oscillation of plasma inorganic phosphate concentration

Published:2018-05 Issue:5 Volume:93 Page:1073-1085
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Miyagawa Atsumi,Tatsumi Sawako,Takahama Wako,Fujii Osamu,Nagamoto Kenta,Kinoshita Emi,Nomura Kengo,Ikuta Kayo,Fujii Toru,Hanazaki Ai,Kaneko Ichiro,Segawa Hiroko,Miyamoto Ken-ichi

Publisher

Elsevier BV

Subject

Nephrology

Reference63 articles.

1. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

2. Hyperphosphatemia of chronic kidney disease;Hruska;Kidney Int,2008

3. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies;Miyamoto;J Pharm Sci,2011

4. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis;Palmer;JAMA,2011

5. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community;Dhingra;Arch Intern Med,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the circadian timing system on drug metabolism and detoxification: an update;Expert Opinion on Drug Metabolism & Toxicology;2024-05-20

2. Effects of the novel sodium-dependent phosphate cotransporter 2b inhibitor DZ1462 on hyperphosphatemia in chronic kidney disease;American Journal of Translational Research;2024

3. Current Perspective on Circadian Function of the Kidney;American Journal of Physiology-Renal Physiology;2023-12-22

4. Intestinal and Renal Adaptations to Changes of Dietary Phosphate Concentrations in Rat;Function;2023-11-13

5. Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial;Clinical Kidney Journal;2023-10-11